Edema

Common Name(s)

Edema

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Edema" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Edema" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Edema" returned 1705 free, full-text research articles on human participants. First 3 results:

Apatinib in refractory radiation-induced brain edema: A case report.
 

Author(s): Wei Guo Hu, Yi Ming Weng, Yi Dong, Xiang Pan Li, Qi-Bin Song

Journal: Medicine (Baltimore). 2017 Nov;96(46):e7358.

 

Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has observed to be effective and safe in refractory radiation-induced brain edema, like Avastin did. Till now, there is no case report after apatinib came in the market.

Last Updated: 31 Dec 1969

Go To URL
Efficacy and safety of bevacizumab treatment for refractory brain edema: Case report.
 

Author(s): Xiangying Meng, Rugang Zhao, Ge Shen, Dapeng Dong, Lijuan Ding, Shikai Wu

Journal: Medicine (Baltimore). 2017 Nov;96(44):e8280.

 

This retrospective study investigated the efficacy and safety of bevacizumab treatment for refractory brain edema.

Last Updated: 31 Dec 1969

Go To URL
Myocardial Edema without Fibrosis by Magnetic Resonance T2 Mapping in Acute Chagas' Myocarditis.
 

Author(s): Andréa Silvestre de Sousa, Maria Eduarda Derenne, Alejandro Marcel Hasslocher-Moreno, Sérgio Salles Xavier, Ilan Gottlieb

Journal: Arq. Bras. Cardiol.. 2017 Oct;109(4):378-379.

 

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Edema" returned 197 free, full-text review articles on human participants. First 3 results:

Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.
 

Author(s): Nikolaos Dervenis, Athanasia Maria Mikropoulou, Paris Tranos, Panagiotis Dervenis

Journal: Adv Ther. 2017 Jun;34(6):1270-1282.

 

Diabetic retinopathy (more specifically diabetic macular edema, DME) is the most common cause of loss of vision in the working population in developed countries. Anti-vascular endothelial growth factor (anti-VEGF) agents considerably changed the treatment algorithms and improved prognosis ...

Last Updated: 31 Dec 1969

Go To URL
Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
 

Author(s): Ursula Schmidt-Erfurth, Jose Garcia-Arumi, Francesco Bandello, Karina Berg, Usha Chakravarthy, Bianca S Gerendas, Jost Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein

Journal: Ophthalmologica. 2017 ;237(4):185-222.

 

Diabetic retinal disease is envisioned to become the plague of the coming decades with a steep increase of worldwide diabetes incidence followed by a substantial rise in retinal disease. Improvements in diagnostic and therapeutic care have to cope with this dilemma in a clinically ...

Last Updated: 31 Dec 1969

Go To URL
Cystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literature.
 

Author(s): Olga E Makri, Foteini N Tsapardoni, Panagiotis Plotas, Nikistratos Ifantis, Paraskevi T Xanthopoulou, Constantine D Georgakopoulos

Journal:

 

Cystoid macular edema associated with latanoprost administration has been reported in patients after complicated cataract surgery with coexisting risk factors. We present the first case of preservative free latanoprost associated cystoid macular edema that occurred many months after ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 24 Apr 2017

Go to URL

Last Updated: 12 Apr 2017

Go to URL

Last Updated: 9 Nov 2017

Go to URL